ifosfamide and resorufin

ifosfamide has been researched along with resorufin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Harimoto, N; Hashimoto, I; Ijima, H; Kawabata, K; Kawakami, K; Mu, C; Sakai, S; Salmons, B; Tanaka, S	1
Düvier, D; Gregor, W; Günzburg, WH; Holzmüller, H; Lengler, J; Omann, M; Renner, M; Salmons, B	1

Other Studies

2 other study(ies) available for ifosfamide and resorufin

Article	Year
Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors. Molecular cancer therapeutics, 2005, Volume: 4, Issue:11 Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biophysics; Cats; Cell Line; Cell Size; Cell Survival; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Humans; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxazines; Particle Size; Sepharose; Temperature; Time Factors	2005
Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy. Biochemical pharmacology, 2006, Sep-28, Volume: 72, Issue:7 Topics: Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cytochrome c Group; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Genetic Therapy; Humans; Ifosfamide; Mice; NADPH-Ferrihemoprotein Reductase; NIH 3T3 Cells; Oxazines; Plasmids; Prodrugs; Transfection	2006

Article

Year

Subsieve-size agarose capsules enclosing ifosfamide-activating cells: a strategy toward chemotherapeutic targeting to tumors.

Molecular cancer therapeutics, 2005, Volume: 4, Issue:11

Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biophysics; Cats; Cell Line; Cell Size; Cell Survival; Cytochrome P-450 CYP2B1; Drug Delivery Systems; Humans; Ifosfamide; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oxazines; Particle Size; Sepharose; Temperature; Time Factors

2005

Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.

Biochemical pharmacology, 2006, Sep-28, Volume: 72, Issue:7

Topics: Animals; Antineoplastic Agents, Alkylating; Blotting, Western; Cell Line; Cell Line, Tumor; Cell Survival; Cytochrome c Group; Cytochrome P-450 CYP2B1; Dose-Response Relationship, Drug; Genetic Therapy; Humans; Ifosfamide; Mice; NADPH-Ferrihemoprotein Reductase; NIH 3T3 Cells; Oxazines; Plasmids; Prodrugs; Transfection

2006